A growing body of evidence supports treating melasma with systemic or intradermal tranexamic acid. But melasma patients often relapse when they stop taking the antifibrinolytic agent, and research on tranexamic acid’s long-term efficacy and safety is limited.
A literature review on clinical evidence for melasma treatments suggests an evidence-based treatment ladder.
Adults 60 years and older tend to have a distinct atopic dermatitis presentation and important comorbidities, but dermatologists treating these patients find lacking evidence on how to diagnose and best treat atopic dermatitis in the elderly, according to a recent review.
The 2019 joint American Academy of Dermatology and National Psoriasis Foundation phototherapy treatment of psoriasis guidelines comprehensively updates dermatologists and other providers on the state-of-the art use of various light modalities to treat psoriasis patients.
Stay up to date on the latest recommendations for rosacea diagnosis, classification and management from the global ROSacea COnsensus (ROSCO) 2019 panel.
Being overweight may have a protective effect on whether adolescents develop acne, according to a new study of more than 600,400 Israeli youth.
Managing an aesthetic or medical practice can be scary. Get tips and tricks from a seasoned pro who practices with 14 other dermatologists and nearly 100 staff members.
Clascoterone 1% cream is in late stage development for acne treatment and in a higher strength solution for androgenetic alopecia. Read more about this novel treatment here.
Expert advice on how to get patients to review your practice and (importantly) put it in a positive light.
Rosacea is often underdetected and misdiagnosed in skin of color patients. This expert wants to increase dermatologists’ awareness of how rosacea might present differently in skin of color and how best to treat it without causing post-inflammatory hyperpigmentation.